Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Wai Chun Bio-TechnologyHKSE:00660 23 Market Cap is HK$159.5 Mil as of Aug. 18, 2026. GuruFocus rates HKSE:00660 with a GF Score™ of 23/100. The stock has 6 warning signs investors should review. Among 1,634 Chemicals companies, Wai Chun Bio-Technology ranks worse than 83.23% on this metric.
Wai Chun Bio-Technology's quarterly market cap
increased
from Dec. 2024 (HK$11.3 Mil) to Jun. 2025 (HK$24.6 Mil) and
increased
from Jun. 2025 (HK$24.6 Mil) to Dec. 2025 (HK$33.6 Mil).
Wai Chun Bio-Technology's annual market cap
increased
from Jun. 2023 (HK$17.5 Mil) to Jun. 2024 (HK$21.4 Mil) and
increased
from Jun. 2024 (HK$21.4 Mil) to Jun. 2025 (HK$24.6 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Wai Chun Bio-Technology's Enterprise Value for Today is HK$324.8 Mil.
Wai Chun Bio-Technology (HKSE:00660) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Wai Chun Bio-Technology Market Cap Related Terms
Wai Chun Bio-Technology Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Wai Chun Bio-Technology's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Wai Chun Bio-Technology Market Cap vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Wai Chun Bio-Technology's Market Cap distribution charts can be found below:
* The bar in red indicates where Wai Chun Bio-Technology's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Wai Chun Bio-Technology's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Wai Chun Bio-Technology (HKSE:00660) has a Market Cap of HK$159.5 Mil as of Aug. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Wai Chun Bio-Technology and its competitors. According to the industry distribution chart, Wai Chun Bio-Technology ranks #1360 out of 1634 companies in the Chemicals industry, placing it in the top 83.2%.
Is Wai Chun Bio-Technology's Market Cap too high?
Wai Chun Bio-Technology's current Market Cap is HK$159.5 Mil. Based on the distribution chart, Wai Chun Bio-Technology ranks #1360 out of 1634 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Wai Chun Bio-Technology has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Wai Chun Bio-Technology's Market Cap compare to DOW?
According to the Chemicals industry distribution chart, Wai Chun Bio-Technology ranks #1360 out of 1634 companies for Market Cap. This places Wai Chun Bio-Technology in the lower half of its industry. The industry median Market Cap is 312.29. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Chemicals company?
The median Market Cap among Chemicals companies is 312.29, based on 1,634 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Wai Chun Bio-Technology and its competitors. For the Chemicals industry, the median Market Cap is 312.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Wai Chun Bio-Technology's current Market Cap is HK$159.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Wai Chun Bio-Technology stock overvalued right now?
Wai Chun Bio-Technology (HKSE:00660) has a current Market Cap of HK$159.5 Mil. The current Market Cap is HK$159.5 Mil. Wai Chun Bio-Technology's overall GF Score™ is 23/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Wai Chun Bio-Technology (HKSE:00660), the current Market Cap is HK$159.5 Mil as of Aug. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Wai Chun Bio-Technology Ltd is an investment holding company. The company has one reportable segmentbeing the manufacturing and sale of modified starch and other biochemical products. It is involved in the manufacturing and sale of modified starch and other biochemical products. Geographically, it derives a majority of its revenue from the People's Republic of China. The company also has its presence in Hong Kong.
23GF Score
Get the complete analysis for HKSE:00660
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:00660 has been successfully added to your 
